Reactions to learning a "not elevated" amyloid PET result in a preclinical Alzheimer's disease trial.
Alzforum,
. Reactions to learning a "not elevated" amyloid PET result in a preclinical Alzheimer's disease trial.
. Reactions to learning a "not elevated" amyloid PET result in a preclinical Alzheimer's disease trial.
The experiences of biomarker-ineligible cognitively normal persons can inform trial conduct and the translation of preclinical…